Showing results (231-240 of 946) with videos related to

Sort By:
Pageof 95
Neuropharmacology|October 1, 1989
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxinA Ueki, P N Chong, A Albanese, et al.
Biochemical Pharmacology|August 1, 1985
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the ratN M Rupniak, M D Hall, S Mann, et al.
European Journal of Pharmacology|January 12, 1993
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosetsS Rose, M Nomoto, E A Jackson, et al.
Psychopharmacology|February 1, 1995
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmosetK K Gnanalingham, D D Erol, A J Hunter, et al.
Psychopharmacology|January 1, 1984
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the ratN M Rupniak, S Mann, M D Hall, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's diseaseF Stocchi, S Ruggieri, A Carta, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTPM D Taylor, M L de Ceballos, S Rose, et al.
Neuroscience Letters|May 15, 1980
Acute motor effects of N-methyl-D-aspartic acid and kainic acid applied focally to mesencephalic dopamine cell body regions in the ratC J Pycock, D Dawbarn
European Journal of Pharmacology|March 3, 1992
Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosetsK W Lange, P A Löschmann, H Wachtel, et al.
Brain Research|January 15, 1990
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in manR Raisman-Vozari, J A Girault, S Moussaoui, et al.
Pageof 95